Tower announces the ‘Evolution’ of the pharmaceutical cold chain

Update : 7th November, 2023

The latest innovation from Tower Cold Chain, a pioneer in passive temperature-controlled containers, offers pharmaceutical manufacturers, airlines and 3PL providers a single solution compatible with U.S. and E.U. pallets – with an ultra-lightweight design.

The Evolution 1600 Tower Universal Pallet, unveiled at CPHI Barcelona 2023, is perfectly adapted to universal shipping needs, meeting industry standards for a truly pan-global container. As such, it gives the pharmaceutical and life sciences markets unparalleled levels of efficiency and versatility in their cold chain operations.

Enabling pharmaceutical shipments for products that need to be kept between -60°C to +20°C with an industry-standard runtime of 120 hours without the need of electricity or manual intervention during transit, Tower has used its extensive experience of cold chain container design to find the optimum balance between size, weight and volumetric efficiency.

“The Evolution 1600 Tower Universal Pallet has been developed in response to the challenges faced in transporting large volumes of pharmaceuticals and life science products around the world. We were inspired to innovate an efficient solution that was not hindered by size, weight, plate or pallet configurations,” says Martin Hawes, Global Head of Product Development at Tower Cold Chain.
“The Evolution 1600 sets new standards for the cold chain industry, offering the same robust, reliable and reusable benefits, but with added flexibility, weight efficiency and space utilisation.”

Each Evolution 1600 is a quarter of the size of a PMC pallet, allowing four containers to be transported per pallet. By analysing data from hundreds of thousands of journeys, Tower has reduced the amount of phase-change materials required to maintain a consistent internal temperature – resulting in significant weight savings and more space for product to be packed.

User convenience is assured throughout. Removable plates enable flexible and sustainable conditioning, with the option to add dry ice for ultra-cold shipments. The Evolution 1600 is designed with double-door access for improved accessibility and safety during loading and unloading.

Customers continue to get the benefits associated with Tower products: a robust design for product protection, reliable temperature control of up to 120 hours, and a reusable system that means the Evolution 1600 can be shipped around the world, hundreds of times – for a substantially reduced carbon footprint versus single-use and heavier alternatives.

With built in data logging technology to provide real-time updates of internal temperature monitoring, the Evolution 1600 is part of Tower’s digital transformation journey to enhance and streamline customer’s access to data visualisation, analysis, and shipping details.

The introduction of the Evolution 1600 coincides with Tower’s international global hub network expansion, bolstering customers’ availability of its robust, reliable, and reusable cold storage solutions. With its latest facilities opening in Switzerland, Italy, and Ireland as well as the launch of its American Centre of Excellence, Tower remains committed to advancing the standard for cold chain logistics on a global scale.

For more information on the Evolution 1600, visit: https://bit.ly/3Mn4E9v

 

About Tower

Tower delivers proven physical and temperature protection for pharmaceutical and life science products and our robust, reliable, and reusable containers are the essential link in the stability of the cold chain.

Headquartered in the UK, we operate a global network ensuring availability and easy access to our products for all customers.

We are trusted by global pharmaceutical, logistics and airline companies and our experienced team, supported by a centralized quality-management system, reinforces customer confidence that our shipping facilities will meet requirements throughout the supply chain. Our patented design technology ensures our solutions meet the pharmaceutical industry performance standard, providing a minimum of 120 hours temperature compliance in any environment, anywhere in the world.

We work closely with our customers, realizing their requirements and how we can address emerging needs. and to deliver customer-focused innovation in temperature-controlled protection.

For Tower sales enquiries please contact:

Nick Gilmore, Global Head of Sales & Marketing
Caroline Suard, Global Marketing Manager
Email: Nick.Gilmore@towercoldchain.com
Email: Caroline.Suard@towercoldchain.com

For Tower media enquiries please contact:
Simon Kinnear, Rhiannon Hopper, or Nielsen McAllister
Tel: +44 (0)1332 293939
Email: tower@nmpr.co.uk

Source : Tower Cold Chain


This news article complies with our Editorial Policy